6505-13-119-4233
Oxaprozine Tablets
6505131194233 131194233 DRAPROX COMP. 30X600MG 1754712 404 IS 39 F 3 M01AE12
INC: 77777
Managed by Belgium
NSN Created on 6 Jul 2006
Data Last Changed
January 2023
January 2023
NATO Update Count
1
1
NATO Data Quality

Marketplace 6505-13-119-4233
Need Help?
Request a Quotation from participating marketplace vendors
Request a Quotation from participating marketplace vendors
Related Documents 6505-13-119-4233 2+ Documents (More...)
DRAPROX COMP. 30X600MG 1754712 404 IS 39 F 3 M01AE12 Managed by Belgium NSN Created on 6 Jul 2006 Data
RQST NE Updated Every Day 6505-13-119-4233 RQST Updated Every Day 6505-13-119-4233 RQST NE Related Documents
6505-13-119-4233 2+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/be 6505-13-119-4233
RQST NE Updated Every Day 6505-13-119-4233 RQST Updated Every Day 6505-13-119-4233 RQST NE Related Documents
6505-13-119-4233 2+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/be 6505-13-119-4233
browser . 6505-13-119-4234Oxaprozine Tablets6505131194234 131194234 DURAPROX COMP. 60X600MG 1754720 M01AE12
www.nsnlookup.com /fsg-65/fsc-6505/be 6505-13-119-4234 https//www.nsnlookup.com /fsg-65/fsc-6505/be 6505-13-119-4233
Oxaprozine Tablets 6505131194233 131194233 13-119-4233Oxaprozine Tablets6505131194233 131194233
www.nsnlookup.com /fsg-65/fsc-6505/be 6505-13-119-4234 https//www.nsnlookup.com /fsg-65/fsc-6505/be 6505-13-119-4233
Oxaprozine Tablets 6505131194233 131194233 13-119-4233Oxaprozine Tablets6505131194233 131194233
Restrictions 6505-13-119-4233
Approved Sources 6505-13-119-4233
- Part Number
- Manufacturer
- Status
- DRAPROX COMP. 30X600MG
- Manufacturer
- B2258 - Tramedico Nv (Active)
- Primary Buy
- Primary Buy
- 1754712
- B6095 - Association Pharmaceutique (Active)
- Secondary Buy
- Secondary Buy
- 404 IS 39 F 3
- B2258 - Tramedico Nv (Active)
- Secondary Buy
- Secondary Buy
- M01AE12
- I9022 - Who Collaborating Centre For Drug (Active)
- Canceled/Obsolete
- Canceled/Obsolete
Similar Supply Items to 6505-13-119-4233

















